Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.
Press releases published on July 9, 2025
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, …
Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité
Jason Campagna, MD, PhD, rejoint Inventiva en tant que Président de la R…
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 ( …
Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These results …
Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license …
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation
OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert Award by the Royal Academy of Engineering. The award, …
Advanced Materials Market in Focus: BCC Research Publishes 2024 Sector Review
Boston, July 09, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its " 2024 Advanced Materials Research Review," offering a deep dive into one of today’s most dynamic and fast-growing markets. This comprehensive report explores the latest …
Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight
New York, USA, July 09, 2025 (GLOBE NEWSWIRE) -- Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight The medical device cleaning market is witnessing steady growth, driven by the …
HOOPP announces changes to its Executive Leadership Team
TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Today, the Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce changes to its executive leadership team. Linda Halley has been promoted to Chief Risk Officer. Linda has been with HOOPP for 24 years …
Press release: Transparency Notification from Shareholders
Transparency Notification from Shareholders Ghent, Belgium – 9 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and …
Investment into Saskatchewan pea protein processing to create new Canadian food options
Yorkton, SK, July 09, 2025 (GLOBE NEWSWIRE) -- The growth of the plant-protein sector has led to rising demand for Canadian-made protein alternatives that meet the flavour and nutrition profiles of their traditional counterparts. Today, Protein Industries …
Medical Teams International Makes Progress Against Sexual and Gender-Based Violence in Ethiopia
ADDIS ABABA, Ethiopia, July 09, 2025 (GLOBE NEWSWIRE) -- Medical Teams International, a global health and humanitarian relief organization, has expanded and enhanced our services in Ethiopia addressing gender-based violence (GBV) and life-saving sexual and …
US Orphan Drug Market Size Trends FDA Designation By Indication Orphan Drug Sales Clinical Research Insight
Delhi, July 09, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …